Basic info
Industry
biotechnology research
Sectors
Biotechnology
Drug Development
Deuterated small molecules
MET kinase inhibitor
Medical
Date founded
2020
Funding rounds raised
Total raised
$6.2M
from 4 investors over 4 rounds
D
DeuterOncology NV raised $6.2M on January 19, 2023
Investors: NEWTON BIOCAPITAL, - and INVESTSUD (Capital & Croissance)
D
DeuterOncology NV raised undisclosed on February 24, 2021
Investors: NEWTON BIOCAPITAL